
Peter Dreger
Articles
-
May 1, 2024 |
nature.com | Ali Bazarbachi |Jürgen Finke |Nicolaus Kröger |Martin Bornhauser |Friedrich Stölzel |Peter Dreger | +4 more
AbstractSecond allogeneic stem cell transplantation (alloSCT2) is among the most effective treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long-term EBMT registry data were used to provide large scale, up-to-date outcome results and to identify factors for improved outcome.
-
Mar 18, 2024 |
nature.com | Romain Guièze |Johannes Schetelig |Jakob Passweg |Jürgen Finke |Mutlu Arat |Friedrich Stölzel | +7 more
AbstractManagement of Richter transformation (RT) is particularly challenging, with survival estimates <1 year. We report on outcomes of 66 RT patients undergoing allogeneic-HCT (allo-HCT) between 2008 and 2018 registered with the EBMT. Median age at allo-HCT was 56.2 years (interquartile range (IQR), 51.3–63.1). Median time from RT to allo-HCT was 6.9 months (IQR, 4.9–11) and 28 (42.4%) were in complete remission (CR).
-
Feb 20, 2024 |
nature.com | Dietrich Wilhelm Beelen |Friedrich Stölzel |Fabio Ciceri |Wolfgang Andreas Bethge |Peter Dreger |Donal McLornan | +2 more
AbstractA randomized study (acronym: MC-FludT.14/L Trial II) demonstrated that fludarabine plus treosulfan (30 g/m²) was an effective and well tolerated conditioning regimen for allogeneic hematopoietic cell transplantation (allo-HCT) in older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
-
Aug 22, 2023 |
kreiszeitung-wochenblatt.de | Peter Dreger
Liebe Immenbecker, liebe Buxtehuder. Unsere wunderschöne Ortseinfahrt Immenbeck direkt führend in die Hansestadt Buxtehude soll nachhaltig für einen zweiten Geh- und Fahrradweg verändert werden!Hierfür sollen 6 CO2 bindende Bäume; in Summe mehr als ca. 300 Jahre Wachstum gefällt werden!An der betroffenen K40 (Kreis Straße) befindet sich bereits seit Jahrzehnten ein kombinierter Geh- und Fahrradweg.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →